Freeline Therapeutics Holdings (Freeline Therapeutics Holdings) YoY EPS Growth : 10.00% (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Freeline Therapeutics Holdings YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Freeline Therapeutics Holdings's YoY EPS Growth for the quarter that ended in Sep. 2023 was 10.00%.

Freeline Therapeutics Holdings's Earnings per Share (Diluted) for the three months ended in Sep. 2023 was $-2.70.

Freeline Therapeutics Holdings YoY EPS Growth Historical Data

The historical data trend for Freeline Therapeutics Holdings's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Freeline Therapeutics Holdings YoY EPS Growth Chart

Freeline Therapeutics Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

YoY EPS Growth

-61.92

19.79

42.29

61.83

Freeline Therapeutics Holdings Quarterly Data
	Dec18	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
YoY EPS Growth	Get a 7-Day Free Trial													76.74	63.92	103.17	33.29	10.00

Freeline Therapeutics Holdings YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Freeline Therapeutics Holdings's YoY EPS Growth for the fiscal year that ended in Dec. 2022 is calculated as:

	YoY EPS Growth (A: Dec. 2022 )
=	(Earnings per Share (Diluted) (A: Dec. 2022 )	-	Earnings per Share (Diluted) (A: Dec. 2021 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2021 ) \|
=	(-22.5	-	-58.95)	/	\| -58.95 \|
=	61.83 %

Freeline Therapeutics Holdings's YoY EPS Growth for the quarter that ended in Sep. 2023 is calculated as:

	YoY EPS Growth (Q: Sep. 2023 )
=	(Earnings per Share (Diluted) (Q: Sep. 2023 )	-	Earnings per Share (Diluted) (Q: Sep. 2022 ))	/	\| Earnings per Share (Diluted) (Q: Sep. 2022 )) \|
=	(-2.7	-	-3)	/	\| -3 \|
=	10.00 %

Freeline Therapeutics Holdings YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Freeline Therapeutics Holdings's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Freeline Therapeutics Holdings (Freeline Therapeutics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Freeline Therapeutics Holdings PLC (NAS:FRLN) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gunnels Wood Road, Sycamore House, Stevenage, Hertfordshire, GBR, SG1 2BP

Website

https://www.freeline.life

Freeline Therapeutics Holdings PLC is a clinical-stage biotechnology company developing transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its lead product candidates are FLT180a for the treatment of hemophilia B, FLT190 for the treatment of Fabry disease and FLT201 for the treatment of Gaucher disease Type 1.